Skip to main content

incPRINT as a platform for RNA-targeted drug discovery

Project description

Novel technology assists the discovery of RNA-targeting drugs

RNA molecules are master regulators of many biological processes, and emerging evidence underscores their role in disease. However, using small molecules to target RNA therapeutically has proven technologically challenging. To address this problem, scientists of the EU-funded incPRINT-DRUG project propose to use their high-throughput RNA–protein interaction technology designed to identify small molecules that target specific pathogenic RNA–protein complexes. This technology simultaneously assesses the efficacy, specificity and toxicity of drugs in living cells. The aim of the incPRINT-DRUG project is to adapt this tool for RNA drug discovery and contribute to the biomedical field.

Host institution

INSTITUT CURIE
Net EU contribution
€ 150 000,00
Address
Rue D'ulm 26
75231 Paris
France

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Non-EU contribution
€ 0,00

Beneficiaries (1)

INSTITUT CURIE
France
Net EU contribution
€ 150 000,00
Address
Rue D'ulm 26
75231 Paris

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Non-EU contribution
€ 0,00